Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 103

1.

Opportunities and challenges of next-generation DNA sequencing for breast units.

Pilgrim SM, Pain SJ, Tischkowitz MD.

Br J Surg. 2014 Jul;101(8):889-98. doi: 10.1002/bjs.9458. Epub 2014 Mar 27. Review.

PMID:
24676784
[PubMed - indexed for MEDLINE]
2.

Use of genetic testing and prophylactic mastectomy and oophorectomy in women with breast or ovarian cancer from families with a BRCA1 or BRCA2 mutation.

Meijers-Heijboer H, Brekelmans CT, Menke-Pluymers M, Seynaeve C, Baalbergen A, Burger C, Crepin E, van den Ouweland AW, van Geel B, Klijn JG.

J Clin Oncol. 2003 May 1;21(9):1675-81.

PMID:
12721241
[PubMed - indexed for MEDLINE]
Free Article
3.

Impact of BRCA1/BRCA2 counseling and testing on newly diagnosed breast cancer patients.

Schwartz MD, Lerman C, Brogan B, Peshkin BN, Halbert CH, DeMarco T, Lawrence W, Main D, Finch C, Magnant C, Pennanen M, Tsangaris T, Willey S, Isaacs C.

J Clin Oncol. 2004 May 15;22(10):1823-9. Epub 2004 Apr 5.

PMID:
15067026
[PubMed - indexed for MEDLINE]
Free Article
4.

Long-range PCR and next-generation sequencing of BRCA1 and BRCA2 in breast cancer.

Ozcelik H, Shi X, Chang MC, Tram E, Vlasschaert M, Di Nicola N, Kiselova A, Yee D, Goldman A, Dowar M, Sukhu B, Kandel R, Siminovitch K.

J Mol Diagn. 2012 Sep;14(5):467-75. doi: 10.1016/j.jmoldx.2012.03.006. Epub 2012 Aug 6.

PMID:
22874498
[PubMed - indexed for MEDLINE]
Free Article
5.

Understanding genetic analysis for breast cancer and its implications for plastic surgery.

Soltanian H, Okada H.

Aesthet Surg J. 2008 Jan-Feb;28(1):85-91. doi: 10.1016/j.asj.2007.10.002. Review.

PMID:
19083511
[PubMed - indexed for MEDLINE]
6.

Detection of genomic variations in BRCA1 and BRCA2 genes by long-range PCR and next-generation sequencing.

Hernan I, Borràs E, de Sousa Dias M, Gamundi MJ, Mañé B, Llort G, Agúndez JA, Blanca M, Carballo M.

J Mol Diagn. 2012 May-Jun;14(3):286-93. doi: 10.1016/j.jmoldx.2012.01.013. Epub 2012 Mar 16.

PMID:
22426013
[PubMed - indexed for MEDLINE]
Free Article
7.

Prevention of breast cancer in women who carry BRCA1 or BRCA2 mutations: a critical review of the literature.

Calderon-Margalit R, Paltiel O.

Int J Cancer. 2004 Nov 10;112(3):357-64. Review.

PMID:
15382059
[PubMed - indexed for MEDLINE]
8.

One year follow-up of women opting for presymptomatic testing for BRCA1 and BRCA2: emotional impact of the test outcome and decisions on risk management (surveillance or prophylactic surgery).

Lodder LN, Frets PG, Trijsburg RW, Meijers-Heijboer EJ, Klijn JG, Seynaeve C, van Geel AN, Tilanus MM, Bartels CC, Verhoog LC, Brekelmans CT, Burger CW, Niermeijer MF.

Breast Cancer Res Treat. 2002 May;73(2):97-112.

PMID:
12088120
[PubMed - indexed for MEDLINE]
9.

Predictors of contralateral prophylactic mastectomy in women with a BRCA1 or BRCA2 mutation: the Hereditary Breast Cancer Clinical Study Group.

Metcalfe KA, Lubinski J, Ghadirian P, Lynch H, Kim-Sing C, Friedman E, Foulkes WD, Domchek S, Ainsworth P, Isaacs C, Tung N, Gronwald J, Cummings S, Wagner T, Manoukian S, Møller P, Weitzel J, Sun P, Narod SA; Hereditary Breast Cancer Clinical Study Group.

J Clin Oncol. 2008 Mar 1;26(7):1093-7. doi: 10.1200/JCO.2007.12.6078. Epub 2008 Jan 14.

PMID:
18195327
[PubMed - indexed for MEDLINE]
Free Article
10.

Similar contributions of BRCA1 and BRCA2 germline mutations to early-onset breast cancer in Germany.

Hamann U, Liu X, Bungardt N, Ulmer HU, Bastert G, Sinn HP.

Eur J Hum Genet. 2003 Jun;11(6):464-7.

PMID:
12774040
[PubMed - indexed for MEDLINE]
Free Article
11.

Breast cancer and ovarian cancer genetics.

Edlich RF, Winters KL, Lin KY.

J Long Term Eff Med Implants. 2005;15(5):533-45. Review.

PMID:
16218901
[PubMed - indexed for MEDLINE]
12.

Presymptomatic DNA testing and prophylactic surgery in families with a BRCA1 or BRCA2 mutation.

Meijers-Heijboer EJ, Verhoog LC, Brekelmans CT, Seynaeve C, Tilanus-Linthorst MM, Wagner A, Dukel L, Devilee P, van den Ouweland AM, van Geel AN, Klijn JG.

Lancet. 2000 Jun 10;355(9220):2015-20.

PMID:
10885351
[PubMed - indexed for MEDLINE]
13.

Spectrum of mutations in BRCA1, BRCA2, CHEK2, and TP53 in families at high risk of breast cancer.

Walsh T, Casadei S, Coats KH, Swisher E, Stray SM, Higgins J, Roach KC, Mandell J, Lee MK, Ciernikova S, Foretova L, Soucek P, King MC.

JAMA. 2006 Mar 22;295(12):1379-88.

PMID:
16551709
[PubMed - indexed for MEDLINE]
14.

BRCA1/BRCA2 germline mutations in locally recurrent breast cancer patients after lumpectomy and radiation therapy: implications for breast-conserving management in patients with BRCA1/BRCA2 mutations.

Turner BC, Harrold E, Matloff E, Smith T, Gumbs AA, Beinfield M, Ward B, Skolnick M, Glazer PM, Thomas A, Haffty BG.

J Clin Oncol. 1999 Oct;17(10):3017-24.

PMID:
10506595
[PubMed - indexed for MEDLINE]
Free Article
15.

How should we discuss genetic testing with women newly diagnosed with breast cancer? Design and implementation of a randomized controlled trial of two models of delivering education about treatment-focused genetic testing to younger women newly diagnosed with breast cancer.

Watts KJ, Meiser B, Mitchell G, Kirk J, Saunders C, Peate M, Duffy J, Kelly PJ, Gleeson M, Barlow-Stewart K, Rahman B, Friedlander M, Tucker K; TFGT Collaborative Group.

BMC Cancer. 2012 Jul 28;12:320. doi: 10.1186/1471-2407-12-320.

PMID:
22838957
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Breast cancer risk perception among women who have undergone prophylactic bilateral mastectomy.

Metcalfe KA, Narod SA.

J Natl Cancer Inst. 2002 Oct 16;94(20):1564-9.

PMID:
12381709
[PubMed - indexed for MEDLINE]
Free Article
17.

Risk of breast cancer recurrence and contralateral breast cancer in relation to BRCA1 and BRCA2 mutation status following breast-conserving surgery and radiotherapy.

Kirova YM, Stoppa-Lyonnet D, Savignoni A, Sigal-Zafrani B, Fabre N, Fourquet A; Institut Curie Breast Cancer Study Group.

Eur J Cancer. 2005 Oct;41(15):2304-11. Epub 2005 Sep 1.

PMID:
16140006
[PubMed - indexed for MEDLINE]
18.

Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers.

Hartmann LC, Sellers TA, Schaid DJ, Frank TS, Soderberg CL, Sitta DL, Frost MH, Grant CS, Donohue JH, Woods JE, McDonnell SK, Vockley CW, Deffenbaugh A, Couch FJ, Jenkins RB.

J Natl Cancer Inst. 2001 Nov 7;93(21):1633-7.

PMID:
11698567
[PubMed - indexed for MEDLINE]
Free Article
19.

18. Genetics of breast cancer.

Irving M, Elmslie F, Berg J.

Int J Clin Pract. 2002 Nov;56(9):677-82. Review.

PMID:
12469982
[PubMed - indexed for MEDLINE]
20.

Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group.

Rebbeck TR, Friebel T, Lynch HT, Neuhausen SL, van 't Veer L, Garber JE, Evans GR, Narod SA, Isaacs C, Matloff E, Daly MB, Olopade OI, Weber BL.

J Clin Oncol. 2004 Mar 15;22(6):1055-62. Epub 2004 Feb 23.

PMID:
14981104
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk